Phagemid for screening antibodies

• Main Authors: BREITLING, FRANK, LITTLE, MELVYN, DR, BRAUNAGEL, MICHAEL, DUEBEL, STEFAN, KLEWINGHAUS, IRIS
• Format: Patent
• Language: English; French; German
• Published: 15.09.2010
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMBINATORIAL CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; COMPOSITIONS THEREOF; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; CULTURE MEDIA; ENZYMOLOGY; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICOLIBRARIES; MEASURING; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; ORGANIC CHEMISTRY; PEPTIDES; PHYSICS; PROCESSES OF PREPARING SUCH COMPOSITIONS; PROCESSES USING MICROORGANISMS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPIRITS; TESTING; VINEGAR; WINE

New phagemide contains DNA (I) encoding a fusion protein (FP) of an antibody (Ab) and full length coliphage pIII protein (II). Ab is a singlechain and FP includes a protease-sensitive region between Ab and (II). Separate DNA sequences encoding Ab and (II) are fused (esp. incorporating a protease cleavage site between them) then the recombinant molecule inserted into a known phagemid.